|
|
Previous Article | Table of Contents | Next Article 
Blood, 1 September 2001, Vol. 98, No. 5, pp. 1408-1415
HEMATOPOIESIS
Erythropoietin (Epo) and EpoR expression and 2 waves of erythropoiesis
Robert Lee,
Nathalie Kertesz,
Sean B. Joseph,
Armin Jegalian, and
Hong Wu
From the Molecular Biology Institute, Department of
Molecular and Medical Pharmacology, and the Howard Hughes Medical
Institute, University of California at Los Angeles School of Medicine.
Erythropoiesis occurs in 2 distinct waves during
embryogenesis: the primitive wave in the extra-embryonic yolk sac (YS)
followed by the definitive wave in the fetal liver and spleen. Even
though progenitors for both cell types are present in the YS blood
islands, only primitive cells are formed in the YS during early
embryogenesis. In this study, it is proposed that erythropoietin (Epo)
expression and the resultant EpoR activation regulate the timing of the
definitive wave. First, it was demonstrated that Epo and EpoR gene
expressions are temporally and spatially segregated: though EpoR is
expressed early (embryonic days 8.0-9.5) in the yolk sac blood islands, no Epo expression can be detected in this extra-embryonic tissue. Only
at a later stage can Epo expression be detected intra-embryonically, and the onset of Epo expression correlates with the initiation of
definitive erythropoiesis. It was further demonstrated that the
activation of the EpoR signaling pathway by knocking-in a constitutively active form of EpoR (R129C EpoR) can lead to earlier onset of definitive erythropoiesis in the YS. Thus, these results provide the first in vivo mechanism as to how 2 erythroid progenitor populations can coexist concurrently in the YS yet always differentiate successively during embryogenesis.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
O. Klimchenko, M. Mori, A. DiStefano, T. Langlois, F. Larbret, Y. Lecluse, O. Feraud, W. Vainchenker, F. Norol, and N. Debili
A common bipotent progenitor generates the erythroid and megakaryocyte lineages in embryonic stem cell-derived primitive hematopoiesis
Blood,
August 20, 2009;
114(8):
1506 - 1517.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Paffett-Lugassy, N. Hsia, P. G. Fraenkel, B. Paw, I. Leshinsky, B. Barut, N. Bahary, J. Caro, R. Handin, and L. I. Zon
Functional conservation of erythropoietin signaling in zebrafish
Blood,
October 1, 2007;
110(7):
2718 - 2726.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A. Oneal, N. M. Gantt, J. D. Schwartz, N. V. Bhanu, Y. T. Lee, J. W. Moroney, C. H. Reed, A. N. Schechter, N. L. C. Luban, and J. L. Miller
Fetal hemoglobin silencing in humans
Blood,
September 15, 2006;
108(6):
2081 - 2086.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Yoon, Y. D. Pastore, V. Divoky, E. Liu, A. E. Mlodnicka, K. Rainey, P. Ponka, G. L. Semenza, A. Schumacher, and J. T. Prchal
Hypoxia-inducible Factor-1 Deficiency Results in Dysregulated Erythropoiesis Signaling and Iron Homeostasis in Mouse Development
J. Biol. Chem.,
September 1, 2006;
281(35):
25703 - 25711.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Glasker, J. Li, J. B. Xia, H. Okamoto, W. Zeng, R. R. Lonser, Z. Zhuang, E. H. Oldfield, and A. O. Vortmeyer
Hemangioblastomas share protein expression with embryonal hemangioblast progenitor cell.
Cancer Res.,
April 15, 2006;
66(8):
4167 - 4172.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. T. Tsai, J. J. Ohab, N. Kertesz, M. Groszer, C. Matter, J. Gao, X. Liu, H. Wu, and S. T. Carmichael
A Critical Role of Erythropoietin Receptor in Neurogenesis and Post-Stroke Recovery
J. Neurosci.,
January 25, 2006;
26(4):
1269 - 1274.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Scortegagna, K. Ding, Q. Zhang, Y. Oktay, M. J. Bennett, M. Bennett, J. M. Shelton, J. A. Richardson, O. Moe, and J. A. Garcia
HIF-2{alpha} regulates murine hematopoietic development in an erythropoietin-dependent manner
Blood,
April 15, 2005;
105(8):
3133 - 3140.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-S. Lee, A. O. Vortmeyer, I. A. Lubensky, T. W.A. Vogel, B. Ikejiri, S. Ferlicot, G. Benoit, S. Giraud, E. H. Oldfield, W. M. Linehan, et al.
Coexpression of Erythropoietin and Erythropoietin Receptor in Von Hippel-Lindau Disease-Associated Renal Cysts and Renal Cell Carcinoma
Clin. Cancer Res.,
February 1, 2005;
11(3):
1059 - 1064.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. B. Beleslin-Cokic, V. P. Cokic, X. Yu, B. B. Weksler, A. N. Schechter, and C. T. Noguchi
Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells
Blood,
October 1, 2004;
104(7):
2073 - 2080.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Heinrich, R. Pelanda, and U. Klingmuller
A mouse model for visualization and conditional mutations in the erythroid lineage
Blood,
August 1, 2004;
104(3):
659 - 666.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Cerdan, A. Rouleau, and M. Bhatia
VEGF-A165 augments erythropoietic development from human embryonic stem cells
Blood,
April 1, 2004;
103(7):
2504 - 2512.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. O. Vortmeyer, S. Frank, S.-Y. Jeong, K. Yuan, B. Ikejiri, Y.-S. Lee, D. Bhowmick, R. R. Lonser, R. Smith, G. Rodgers, et al.
Developmental Arrest of Angioblastic Lineage Initiates Tumorigenesis in von Hippel-Lindau Disease
Cancer Res.,
November 1, 2003;
63(21):
7051 - 7055.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Vallet, H. G. Klemcke, R. K. Christenson, and P. L. Pearson
The effect of breed and intrauterine crowding on fetal erythropoiesis on day 35 of gestation in swine
J Anim Sci,
September 1, 2003;
81(9):
2352 - 2356.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Sugiyama, M. Ogawa, I. Hirose, T. Jaffredo, K.-i. Arai, and K. Tsuji
Erythropoiesis from acetyl LDL incorporating endothelial cells at the preliver stage
Blood,
June 15, 2003;
101(12):
4733 - 4738.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Xie, R. J. Chan, S. A. Johnson, M. Starr, J. McCarthy, R. Kapur, and M. C. Yoder
Thrombopoietin promotes mixed lineage and megakaryocytic colony-forming cell growth but inhibits primitive and definitive erythropoiesis in cells isolated from early murine yolk sacs
Blood,
February 15, 2003;
101(4):
1329 - 1335.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Suzuki, O. Ohneda, S. Takahashi, M. Higuchi, H. Y. Mukai, T. Nakahata, S. Imagawa, and M. Yamamoto
Erythroid-specific expression of the erythropoietin receptor rescued its null mutant mice from lethality
Blood,
September 18, 2002;
100(7):
2279 - 2288.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. G. Jegalian, A. Acurio, G. Dranoff, and H. Wu
Erythropoietin receptor haploinsufficiency and in vivo interplay with granulocyte-macrophage colony-stimulating factor and interleukin 3
Blood,
April 1, 2002;
99(7):
2603 - 2605.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|